Table 3.
Associations between adipose tissue distribution parameters and disease-specific survival by multivariate Cox analysis in patients with gastric cancer.
| High SAT percent | High VAT percent | VAT/SAT ratio | ||||
|---|---|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
| Adipose tissue distribution parameter | 0.59 (0.36, 0.96) | 0.032 | 1.68 (1.06, 2.68) | 0.028 | 1.99 (1.19, 3.34) | 0.009 |
| Overweight/obesity | 0.56 (0.34, 0.91) | 0.021 | 0.55 (0.34, 0.91) | 0.019 | 0.55 (0.33, 0.90) | 0.017 |
| Age (>65 years) | 1.56 (1.13, 2.17) | 0.008 | 1.54 (1.11, 2.14) | 0.010 | 1.56 (1.12, 2.16) | 0.008 |
| Female | 0.98 (0.69, 1.4) | 0.929 | 0.93 (0.66, 1.32) | 0.696 | 0.95 (0.67, 1.35) | 0.794 |
| T category | ||||||
| T1 | 1 | 1 | 1 | |||
| T2 | 2.51 (0.88, 7.13) | 0.085 | 2.49 (0.87, 7.08) | 0.880 | 2.49 (0.88, 7.07) | 0.087 |
| T3 | 2.77 (0.52, 14.66) | 0.230 | 2.86 (0.54, 15.09) | 0.216 | 2.81 (0.53, 14.77) | 0.223 |
| T4a | 3.59 (1.45, 8.88) | 0.006 | 3.61 (1.46, 8.95) | 0.006 | 3.63 (1.47, 8.95) | 0.005 |
| T4b | 10.44 (3.35, 32.47) | <0.001 | 10.39 (3.34, 32.31) | <0.001 | 10.73 (3.47, 33.20) | <0.001 |
| N category | ||||||
| N0 | 1 | 1 | 1 | |||
| N1 | 2.38 (1.21, 4.68) | 0.012 | 2.31 (1.17, 4.57) | 0.016 | 2.33 (1.18, 4.60) | 0.015 |
| N2 | 2.45 (1.3, 4.61) | 0.005 | 2.35 (1.25, 4.43) | 0.008 | 2.42 (1.29, 4.54) | 0.006 |
| N3a | 6.74 (3.63, 12.51) | <0.001 | 6.55 (3.53, 12.14) | <0.001 | 6.65 (3.60, 12.30) | <0.001 |
| N3b | 9.01 (4.47, 18.15) | <0.001 | 8.65 (4.3, 17.4) | <0.001 | 8.96 (4.46, 18.01) | <0.001 |
| Chemotherapy | 0.82 (0.54, 1.25) | 0.356 | 0.81 (0.54, 1.23) | 0.329 | 0.82 (0.54, 1.24) | 0.340 |
BMI, body mass index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; HR, hazard ratios; CI, confidence interval.
Bold values represent statistically significant differences (P < 0.05).